T
HALO icon

Tidemark’s Halozyme HALO Stock Holding History

Tidemark’s Portfolio HALO Stock Details HALO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$22.5K Hold
288
– – 0.01% 396
2026
Q1 		$18.6K Hold
288
– – ﹤0.01% 379
2025
Q4 		$19.4K Hold
288
– – 0.01% 355
2025
Q3 		$21.1K Sell
288
-166
-37% -$11K 0.01% 351
2025
Q2 		$23.6K Buy
454
+362
+393% +$20.6K 0.01% 342
2025
Q1 		$5.87K Buy
+92
New +$5.34K ﹤0.01% 497

Other funds holding HALO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Tidemark's HALO Position: Q2 2026 in Review

Tidemark held its Halozyme (HALO) position steady in Q2 2026 at 288 shares worth $22.5K. The position accounts for 0.01% of the portfolio, ranked #396.

Tidemark first reported a position in HALO in Q1 2025 and has held it in 6 quarters since. The position peaked at $23.6K in Q2 2025. 668 funds tracked by Wall St. Rank hold HALO as of Q2 2026.

  • Tidemark held 288 shares of Halozyme worth $22.5K as of Q2 2026.
  • Tidemark left its Halozyme share count unchanged in Q2 2026.
  • Halozyme made up 0.01% of Tidemark's portfolio in Q2 2026, its #396 holding.
  • Tidemark first reported a position in Halozyme in Q1 2025 and has held it in 6 quarters since.
  • Tidemark's Halozyme position peaked at $23.6K in Q2 2025.
  • 668 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.

Based on Tidemark's 13F filing for Q2 2026, filed 10 Aug 2026.